Sunday, May 31, 2026
ADVT 
International

232 confirmed dead in Jan 1 Japan earthquake

Darpan News Desk IANS, 17 Jan, 2024 02:46 PM
  • 232 confirmed dead in Jan 1 Japan earthquake

Tokyo, Jan 17 (IANS) At least 232 people have been confirmed dead in the devastating 7.6-magnitude earthquake that struck Japan's Ishikawa prefecture on January 1, local officials said on Wednesday.

According to the prefectural government, the death toll was updated on Wednesday morning after an additional 10 casualties was reported by the city of Wajima, one of the worst-hit by the massive temblor, reports Xinhua news agency.

Local authorities said these fatalities were discovered in the vicinity of the Wajima Morning Market, a popular tourist spot that suffered extensive damage in the earthquake-triggered fires immediately following the seismic event.

Since last week, the Wajima Morning Market has been the focus of large-scale search and rescue operations.

The number of individuals unaccounted for has decreased by one, leaving Wajima city with 17 missing persons and Suzu city with four, totaling 21 people.

According to local media reports, the damage to residences has reached a staggering 22,374 confirmed cases, and there is a high likelihood that the number of affected buildings will significantly increase as further assessments are conducted.

In cities of Wajima and Suzu, the extent of the damage is still described as "numerous", with the actual situation remaining unclear, reported national news agency Kyodo.

The January 1 temblor, officially named 2024 Noto Peninsula Earthquake, is the first to kill more than 100 people in the country since the 2016 Kumamoto tremors in Japan's southwestern region, which claimed 276 lives.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine